Dr. Alex Kral
Dr. Alex Kral is an epidemiologist and Distinguished Fellow at the nonprofit health research institute RTI International. He has been conducting community-based, policy-directed research on drug use and its attendant health consequences in the United States for three decades. He has published over 200 papers in top peer-reviewed journals and is currently the principal investigator and coinvestigator on several National Institute on Drug Abuse funded projects. He leads a large-scale Arnold Ventures supported evaluation of the impact of Oregon’s Measure 110, which decriminalized drugs and invested in substance use disorder treatment and harm reduction services. Dr. Kral has a bachelor’s degree from Georgetown University, a master’s degree from Harvard University, and a PhD from University of California Berkeley.